Shuhei Teranishi

<scp>MicroRNA</scp>‐200b is a potential biomarker of the expression of <scp>PD‐L1</scp> in patients with lung cancer

Seigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto et al. · Thoracic Cancer · 2020 · 20 citations · Full text

Medicine, Immunology, Oncology +16

Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor

Sousuke Kubo, Nobuaki Kobayashi, Kohei Somekawa et al. · Anticancer Research · 2020 · 17 citations · Full text

Medicine, Immunology, Oncology +17

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial

Hiromi Matsumoto, Nobuaki Kobayashi, Kohei Somekawa et al. · Thoracic Cancer · 2021 · 16 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Retrospective analysis of independent predictors of progression‐free survival in patients with <scp><i>EGFR</i> mutation‐positive</scp> advanced non‐small cell lung cancer receiving first‐line osimertinib

Shuhei Teranishi, Chihiro Sugimoto, Satoshi Nagaoka et al. · Thoracic Cancer · 2022 · 16 citations · Full text

Medicine, Oncology, Pharmacology +15

Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan

Seigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto et al. · Tuberculosis · 2020 · 15 citations

Public Health, Immunology, Infectious Diseases +17